Roy Strowd

, Associate Professor of Neurology, Has Been Named Vice Dean for Undergraduate Medical Education After Serving in That Role on an Interim Basis. · Wake Forest University Baptist Medical Center

Credentials: · · · · ·

History

Wake Forest University Baptist Medical Center
Present
Wake Forest University Baptist Medical Center
Present
Wake Forest University Baptist Medical Center
Present

Hematology and Medical Oncology
Wake Forest University Baptist Medical Center
2013–2016
Bowman Gray School of Medicine
2009–2013
Internal Medicine
Wake Forest University Baptist Medical Center
2010–2013
Wake Forest Univ Sch of Med
2005–2009

Research

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline
Systematic review or meta-analysis · Journal of Clinical Oncology · 2022 · 177 citations
Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients
Tomography · 2015 · 159 citations
Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput
Micromachines · 2020 · 136 citations

Glenn Lesser
30 papers
Stephen Tatter
23 papers
Michael Chan
22 papers
JM
John Millichap
21 papers · 10 as a fellow
Adrian Laxton
19 papers
SG
Stuart Grossman
18 papers
Charlene Gamaldo
14 papers
Jaishri Blakeley
12 papers
Christina Cramer
10 papers · 1 as a resident
EM
Emory McTyre
9 papers · 6 as a resident
MH
Matthias Holdhoff
9 papers
Whitley Aamodt
9 papers

Grants

Wake Forest NeuroNext Clinical Site (WAKENN)
National Institute of Neurological Disorders and Stroke · U24
PI · $1.7M · Wake Forest University Health Sciences
2023–2028
IRE1a-XBP1 Signaling as a Driver of Chemotherapy-Induced Peripheral Neuropathy
National Cancer Institute · R21
PI · $419.5K · Wake Forest University Health Sciences
2020–2022
Predicting Tumor Heterogeneity Evolution After Therapy in Patient-Derived Ex Vivo Glioblastoma Organoids
National Cancer Institute · R21
PI · $597.3K · Ohio State University
2018–2022

Clinical trials

Cereset for Caregivers
Principal investigator · Withdrawn
Wake Forest University Health Sciences
2024
Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
Principal investigator · Terminated · Phase 2
Wake Forest University Health Sciences
2021
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy
Principal investigator · Completed
Wake Forest University Health Sciences
2019–2025
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Principal investigator · Suspended
Wake Forest University Health Sciences
2019–2027